APO Research
Talk to an analyst

APO RESEARCH · REPORT

RNA Stabilizers

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global RNA Stabilizers Industry Growth and Trends Forecast to 2032

26 December 2025118 pages

Choose your research edition.

Industry ResearchRNA Stabilizers Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal RNA Stabilizers Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal RNA Stabilizers Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal RNA Stabilizers Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal RNA Stabilizers Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global RNA Stabilizers market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for RNA Stabilizers is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of RNA Stabilizers include Yeasen, YaJi Biological, NCM Biotech, Thermo Fisher Scientific, Vazyme, Merck, Maokangbio, Beyotime and Zymo Research, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global RNA Stabilizers market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The RNA Stabilizers market size, estimates, and forecasts are presented in terms of sales volume (L) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global RNA Stabilizers market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to RNA Stabilizers.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global RNA Stabilizers market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

RNA Stabilizers Market by Company

Yeasen

YaJi Biological

NCM Biotech

Thermo Fisher Scientific

Vazyme

Merck

Maokangbio

Beyotime

Zymo Research

Takara Bio

SRL

Omega Bio-Tek

NZYtech

New England Biolabs

Genetix Biotech Asia

G-Biosciences

Dutscher

BioEntist

RNA Stabilizers Segment by Type

Solid Phase Stabilizers

Spray or Coating-Based Stabilizers

Solution-Based Stabilizers

RNA Stabilizers Segment by Application

Molecular Biology

Genomics

RNA Stabilizers Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global RNA Stabilizers market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of RNA Stabilizers and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of RNA Stabilizers.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of RNA Stabilizers manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of RNA Stabilizers in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Solid Phase Stabilizers Table 2. Major Company of Spray or Coating-Based Stabilizers Table 3. Major Company of Solution-Based Stabilizers Table 4. Global RNA Stabilizers Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global RNA Stabilizers Sales by Type (2021-2026) & (L) Table 6. Global RNA Stabilizers Sales Market Share in Volume by Type (2021-2026) Table 7. Global RNA Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 8. Global RNA Stabilizers Sales Market Share in Value by Type (2021-2026) Table 9. Global RNA Stabilizers Price by Type (2021-2026) & (US$/ml) Table 10. Global RNA Stabilizers Sales by Type (2027-2032) & (L) Table 11. Global RNA Stabilizers Sales Market Share in Volume by Type (2027-2032) Table 12. Global RNA Stabilizers Sales by Type (2027-2032) & (US$ Million) Table 13. Global RNA Stabilizers Sales Market Share in Value by Type (2027-2032) Table 14. Global RNA Stabilizers Price by Type (2027-2032) & (US$/ml) Table 15. North America RNA Stabilizers Sales by Type (2021-2026) & (L) Table 16. North America RNA Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 17. Europe RNA Stabilizers Sales by Type (2021-2026) & (L) Table 18. Europe RNA Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific RNA Stabilizers Sales by Type (2021-2026) & (L) Table 20. Asia-Pacific RNA Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America RNA Stabilizers Sales by Type (2021-2026) & (L) Table 22. Latin America RNA Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa RNA Stabilizers Sales by Type (2021-2026) & (L) Table 24. Middle East and Africa RNA Stabilizers Sales by Type (2021-2026) & (US$ Million) Table 25. RNA Stabilizers Industry Trends Table 26. RNA Stabilizers Industry Drivers Table 27. RNA Stabilizers Industry Opportunities and Challenges Table 28. RNA Stabilizers Industry Restraints Table 29. Global RNA Stabilizers Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global RNA Stabilizers Revenue Market Share by Company (2021-2026) Table 31. Global RNA Stabilizers Sales by Company (2021-2026) & (L) Table 32. Global RNA Stabilizers Sales Share by Company (2021-2026) Table 33. Global RNA Stabilizers Market Price by Company (2021-2026) & (US$/ml) Table 34. Global RNA Stabilizers Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global RNA Stabilizers Major Company Production Sites and Headquarters Table 36. Global RNA Stabilizers Company, Product Type & Application Table 37. Global RNA Stabilizers Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global RNA Stabilizers by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global RNA Stabilizers Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global RNA Stabilizers Sales by Region (2021-2026) & (L) Table 42. Global RNA Stabilizers Sales Market Share in Volume by Region (2021-2026) Table 43. Global RNA Stabilizers Sales by Region (2021-2026) & (US$ Million) Table 44. Global RNA Stabilizers Sales Market Share in Value by Region (2021-2026) Table 45. Global RNA Stabilizers Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 46. Global RNA Stabilizers Sales by Region (2027-2032) & (L) Table 47. Global RNA Stabilizers Sales Market Share in Volume by Region (2027-2032) Table 48. Global RNA Stabilizers Sales by Region (2027-2032) & (US$ Million) Table 49. Global RNA Stabilizers Sales Market Share in Value by Region (2027-2032) Table 50. Global RNA Stabilizers Sales (L), Value (US$ Million), Price (US$/ml) and Gross Margin (2027-2032) Table 51. Global RNA Stabilizers Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global RNA Stabilizers Sales by Application (2021-2026) & (L) Table 53. Global RNA Stabilizers Sales Market Share in Volume by Application (2021-2026) Table 54. Global RNA Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 55. Global RNA Stabilizers Sales Market Share in Value by Application (2021-2026) Table 56. Global RNA Stabilizers Price by Application (2021-2026) & (US$/ml) Table 57. Global RNA Stabilizers Sales by Application (2027-2032) & (L) Table 58. Global RNA Stabilizers Sales Market Share in Volume by Application (2027-2032) Table 59. Global RNA Stabilizers Sales by Application (2027-2032) & (US$ Million) Table 60. Global RNA Stabilizers Sales Market Share in Value by Application (2027-2032) Table 61. Global RNA Stabilizers Price by Application (2027-2032) & (US$/ml) Table 62. North America RNA Stabilizers Sales by Application (2021-2026) & (L) Table 63. North America RNA Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 64. Europe RNA Stabilizers Sales by Application (2021-2026) & (L) Table 65. Europe RNA Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific RNA Stabilizers Sales by Application (2021-2026) & (L) Table 67. Asia-Pacific RNA Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America RNA Stabilizers Sales by Application (2021-2026) & (L) Table 69. Latin America RNA Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa RNA Stabilizers Sales by Application (2021-2026) & (L) Table 71. Middle East and Africa RNA Stabilizers Sales by Application (2021-2026) & (US$ Million) Table 72. Yeasen Company Information Table 73. Yeasen Business Overview Table 74. Yeasen RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 75. Yeasen RNA Stabilizers Product Portfolio Table 76. Yeasen Recent Development Table 77. YaJi Biological Company Information Table 78. YaJi Biological Business Overview Table 79. YaJi Biological RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 80. YaJi Biological RNA Stabilizers Product Portfolio Table 81. YaJi Biological Recent Development Table 82. NCM Biotech Company Information Table 83. NCM Biotech Business Overview Table 84. NCM Biotech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 85. NCM Biotech RNA Stabilizers Product Portfolio Table 86. NCM Biotech Recent Development Table 87. Thermo Fisher Scientific Company Information Table 88. Thermo Fisher Scientific Business Overview Table 89. Thermo Fisher Scientific RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 90. Thermo Fisher Scientific RNA Stabilizers Product Portfolio Table 91. Thermo Fisher Scientific Recent Development Table 92. Vazyme Company Information Table 93. Vazyme Business Overview Table 94. Vazyme RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 95. Vazyme RNA Stabilizers Product Portfolio Table 96. Vazyme Recent Development Table 97. Merck Company Information Table 98. Merck Business Overview Table 99. Merck RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 100. Merck RNA Stabilizers Product Portfolio Table 101. Merck Recent Development Table 102. Maokangbio Company Information Table 103. Maokangbio Business Overview Table 104. Maokangbio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 105. Maokangbio RNA Stabilizers Product Portfolio Table 106. Maokangbio Recent Development Table 107. Beyotime Company Information Table 108. Beyotime Business Overview Table 109. Beyotime RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 110. Beyotime RNA Stabilizers Product Portfolio Table 111. Beyotime Recent Development Table 112. Zymo Research Company Information Table 113. Zymo Research Business Overview Table 114. Zymo Research RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 115. Zymo Research RNA Stabilizers Product Portfolio Table 116. Zymo Research Recent Development Table 117. Takara Bio Company Information Table 118. Takara Bio Business Overview Table 119. Takara Bio RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 120. Takara Bio RNA Stabilizers Product Portfolio Table 121. Takara Bio Recent Development Table 122. SRL Company Information Table 123. SRL Business Overview Table 124. SRL RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 125. SRL RNA Stabilizers Product Portfolio Table 126. SRL Recent Development Table 127. Omega Bio-Tek Company Information Table 128. Omega Bio-Tek Business Overview Table 129. Omega Bio-Tek RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 130. Omega Bio-Tek RNA Stabilizers Product Portfolio Table 131. Omega Bio-Tek Recent Development Table 132. NZYtech Company Information Table 133. NZYtech Business Overview Table 134. NZYtech RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 135. NZYtech RNA Stabilizers Product Portfolio Table 136. NZYtech Recent Development Table 137. New England Biolabs Company Information Table 138. New England Biolabs Business Overview Table 139. New England Biolabs RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 140. New England Biolabs RNA Stabilizers Product Portfolio Table 141. New England Biolabs Recent Development Table 142. Genetix Biotech Asia Company Information Table 143. Genetix Biotech Asia Business Overview Table 144. Genetix Biotech Asia RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 145. Genetix Biotech Asia RNA Stabilizers Product Portfolio Table 146. Genetix Biotech Asia Recent Development Table 147. G-Biosciences Company Information Table 148. G-Biosciences Business Overview Table 149. G-Biosciences RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 150. G-Biosciences RNA Stabilizers Product Portfolio Table 151. G-Biosciences Recent Development Table 152. Dutscher Company Information Table 153. Dutscher Business Overview Table 154. Dutscher RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 155. Dutscher RNA Stabilizers Product Portfolio Table 156. Dutscher Recent Development Table 157. BioEntist Company Information Table 158. BioEntist Business Overview Table 159. BioEntist RNA Stabilizers Sales (L), Revenue (US$ Million), Price (US$/ml) and Gross Margin (2021-2026) Table 160. BioEntist RNA Stabilizers Product Portfolio Table 161. BioEntist Recent Development Table 162. North America RNA Stabilizers Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 163. North America RNA Stabilizers Sales by Country (2021-2026) & (L) Table 164. North America RNA Stabilizers Sales Market Share by Country (2021-2026) Table 165. North America RNA Stabilizers Sales Forecast by Country (2027-2032) & (L) Table 166. North America RNA Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 167. North America RNA Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America RNA Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 169. North America RNA Stabilizers Market Share by Country (2021-2026) Table 170. North America RNA Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America RNA Stabilizers Market Share Forecast by Country (2027-2032) Table 172. Europe RNA Stabilizers Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 173. Europe RNA Stabilizers Sales by Country (2021-2026) & (L) Table 174. Europe RNA Stabilizers Sales Market Share by Country (2021-2026) Table 175. Europe RNA Stabilizers Sales Forecast by Country (2027-2032) & (L) Table 176. Europe RNA Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 177. Europe RNA Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe RNA Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe RNA Stabilizers Market Share by Country (2021-2026) Table 180. Europe RNA Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe RNA Stabilizers Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific RNA Stabilizers Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific RNA Stabilizers Sales by Country (2021-2026) & (L) Table 184. Asia-Pacific RNA Stabilizers Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific RNA Stabilizers Sales Forecast by Country (2027-2032) & (L) Table 186. Asia-Pacific RNA Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific RNA Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific RNA Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific RNA Stabilizers Market Share by Country (2021-2026) Table 190. Asia-Pacific RNA Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific RNA Stabilizers Market Share Forecast by Country (2027-2032) Table 192. Latin America RNA Stabilizers Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 193. Latin America RNA Stabilizers Sales by Country (2021-2026) & (L) Table 194. Latin America RNA Stabilizers Sales Market Share by Country (2021-2026) Table 195. Latin America RNA Stabilizers Sales Forecast by Country (2027-2032) & (L) Table 196. Latin America RNA Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America RNA Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America RNA Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America RNA Stabilizers Market Share by Country (2021-2026) Table 200. Latin America RNA Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America RNA Stabilizers Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa RNA Stabilizers Market Size Growth Rate (CAGR) by Country (L): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa RNA Stabilizers Sales by Country (2021-2026) & (L) Table 204. Middle East and Africa RNA Stabilizers Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa RNA Stabilizers Sales Forecast by Country (2027-2032) & (L) Table 206. Middle East and Africa RNA Stabilizers Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa RNA Stabilizers Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa RNA Stabilizers Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa RNA Stabilizers Market Share by Country (2021-2026) Table 210. Middle East and Africa RNA Stabilizers Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa RNA Stabilizers Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. RNA Stabilizers Distributors List Table 215. RNA Stabilizers Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. RNA Stabilizers Image Figure 2. Global RNA Stabilizers Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global RNA Stabilizers Market Size (2021-2032) & (US$ Million) Figure 4. Global RNA Stabilizers Sales (2021-2032) & (L) Figure 5. Solid Phase Stabilizers Image Figure 6. Global Solid Phase Stabilizers Sales YoY Growth (2021-2032) & (L) Figure 7. Spray or Coating-Based Stabilizers Image Figure 8. Global Spray or Coating-Based Stabilizers Sales YoY Growth (2021-2032) & (L) Figure 9. Solution-Based Stabilizers Image Figure 10. Global Solution-Based Stabilizers Sales YoY Growth (2021-2032) & (L) Figure 11. Global RNA Stabilizers Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global RNA Stabilizers Market Share by Type 2025 VS 2032 Figure 13. North America RNA Stabilizers Sales Market Share in Volume by Type in 2025 Figure 14. North America RNA Stabilizers Sales Market Share in Value by Type in 2025 Figure 15. Europe RNA Stabilizers Sales Market Share in Volume by Type in 2025 Figure 16. Europe RNA Stabilizers Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific RNA Stabilizers Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific RNA Stabilizers Sales Market Share in Value by Type in 2025 Figure 19. Latin America RNA Stabilizers Sales Market Share in Volume by Type in 2025 Figure 20. Latin America RNA Stabilizers Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa RNA Stabilizers Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa RNA Stabilizers Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 RNA Stabilizers Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Molecular Biology Image Figure 26. Global Molecular Biology Sales YoY Growth (2021-2032) & (L) Figure 27. Genomics Image Figure 28. Global Genomics Sales YoY Growth (2021-2032) & (L) Figure 29. Global RNA Stabilizers Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global RNA Stabilizers Market Share by Application 2025 VS 2032 Figure 31. North America RNA Stabilizers Sales Market Share in Volume by Application in 2025 Figure 32. North America RNA Stabilizers Sales Market Share in Value by Application in 2025 Figure 33. Europe RNA Stabilizers Sales Market Share in Volume by Application in 2025 Figure 34. Europe RNA Stabilizers Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific RNA Stabilizers Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific RNA Stabilizers Sales Market Share in Value by Application in 2025 Figure 37. Latin America RNA Stabilizers Sales Market Share in Volume by Application in 2025 Figure 38. Latin America RNA Stabilizers Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa RNA Stabilizers Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa RNA Stabilizers Sales Market Share in Value by Application in 2025 Figure 41. North America RNA Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 42. North America RNA Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America RNA Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe RNA Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 46. Europe RNA Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe RNA Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific RNA Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 50. Asia-Pacific RNA Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific RNA Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America RNA Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 54. Latin America RNA Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America RNA Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa RNA Stabilizers Sales by Country: 2021 VS 2025 VS 2032 (L) Figure 58. Middle East and Africa RNA Stabilizers Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa RNA Stabilizers Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa RNA Stabilizers Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. RNA Stabilizers Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. RNA Stabilizers Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Solid Phase Stabilizers
  • Spray or Coating-Based Stabilizers
  • Solution-Based Stabilizers
Applications
  • Molecular Biology
  • Genomics
Companies covered
  • Yeasen
  • YaJi Biological
  • NCM Biotech
  • Thermo Fisher Scientific
  • Vazyme
  • Merck
  • Maokangbio
  • Beyotime
  • Zymo Research
  • Takara Bio
  • SRL
  • Omega Bio-Tek
  • NZYtech
  • New England Biolabs
  • Genetix Biotech Asia
  • G-Biosciences
  • Dutscher
  • BioEntist

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global RNA Stabilizers Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global RNA Stabilizers Sales Estimates and Forecasts (2021-2032)
  5. 1.3 RNA Stabilizers Market by Type
  6. 1.3.1 Solid Phase Stabilizers
  7. 1.3.2 Spray or Coating-Based Stabilizers
  8. 1.3.3 Solution-Based Stabilizers
  9. 1.4 Global RNA Stabilizers Market Size by Type
  10. 1.4.1 Global RNA Stabilizers Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global RNA Stabilizers Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global RNA Stabilizers Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America RNA Stabilizers Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe RNA Stabilizers Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific RNA Stabilizers Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America RNA Stabilizers Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa RNA Stabilizers Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 RNA Stabilizers Industry Trends
  2. 2.2 RNA Stabilizers Industry Drivers
  3. 2.3 RNA Stabilizers Industry Opportunities and Challenges
  4. 2.4 RNA Stabilizers Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by RNA Stabilizers Revenue (2021-2026)
  2. 3.2 Global Top Players by RNA Stabilizers Sales (2021-2026)
  3. 3.3 Global Top Players by RNA Stabilizers Price (2021-2026)
  4. 3.4 Global RNA Stabilizers Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global RNA Stabilizers Major Company Production Sites & Headquarters
  6. 3.6 Global RNA Stabilizers Company, Product Type & Application
  7. 3.7 Global RNA Stabilizers Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global RNA Stabilizers Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 RNA Stabilizers Players Market Share by Revenue in 2025
  11. 3.8.3 2025 RNA Stabilizers Tier 1, Tier 2, and Tier 3
4 RNA Stabilizers Regional Status and Outlook
  1. 4.1 Global RNA Stabilizers Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global RNA Stabilizers Historic Market Size by Region
  3. 4.2.1 Global RNA Stabilizers Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global RNA Stabilizers Sales in Value by Region (2021-2026)
  5. 4.2.3 Global RNA Stabilizers Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global RNA Stabilizers Forecasted Market Size by Region
  7. 4.3.1 Global RNA Stabilizers Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global RNA Stabilizers Sales in Value by Region (2027-2032)
  9. 4.3.3 Global RNA Stabilizers Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 RNA Stabilizers by Application
  1. 5.1 RNA Stabilizers Market by Application
  2. 5.1.1 Molecular Biology
  3. 5.1.2 Genomics
  4. 5.2 Global RNA Stabilizers Market Size by Application
  5. 5.2.1 Global RNA Stabilizers Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global RNA Stabilizers Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global RNA Stabilizers Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America RNA Stabilizers Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe RNA Stabilizers Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific RNA Stabilizers Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America RNA Stabilizers Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa RNA Stabilizers Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Yeasen
  2. 6.1.1 Yeasen Company Information
  3. 6.1.2 Yeasen Business Overview
  4. 6.1.3 Yeasen RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Yeasen RNA Stabilizers Product Portfolio
  6. 6.1.5 Yeasen Recent Developments
  7. 6.2 YaJi Biological
  8. 6.2.1 YaJi Biological Company Information
  9. 6.2.2 YaJi Biological Business Overview
  10. 6.2.3 YaJi Biological RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 YaJi Biological RNA Stabilizers Product Portfolio
  12. 6.2.5 YaJi Biological Recent Developments
  13. 6.3 NCM Biotech
  14. 6.3.1 NCM Biotech Company Information
  15. 6.3.2 NCM Biotech Business Overview
  16. 6.3.3 NCM Biotech RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 NCM Biotech RNA Stabilizers Product Portfolio
  18. 6.3.5 NCM Biotech Recent Developments
  19. 6.4 Thermo Fisher Scientific
  20. 6.4.1 Thermo Fisher Scientific Company Information
  21. 6.4.2 Thermo Fisher Scientific Business Overview
  22. 6.4.3 Thermo Fisher Scientific RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Scientific RNA Stabilizers Product Portfolio
  24. 6.4.5 Thermo Fisher Scientific Recent Developments
  25. 6.5 Vazyme
  26. 6.5.1 Vazyme Company Information
  27. 6.5.2 Vazyme Business Overview
  28. 6.5.3 Vazyme RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Vazyme RNA Stabilizers Product Portfolio
  30. 6.5.5 Vazyme Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Merck RNA Stabilizers Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 Maokangbio
  38. 6.7.1 Maokangbio Company Information
  39. 6.7.2 Maokangbio Business Overview
  40. 6.7.3 Maokangbio RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Maokangbio RNA Stabilizers Product Portfolio
  42. 6.7.5 Maokangbio Recent Developments
  43. 6.8 Beyotime
  44. 6.8.1 Beyotime Company Information
  45. 6.8.2 Beyotime Business Overview
  46. 6.8.3 Beyotime RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Beyotime RNA Stabilizers Product Portfolio
  48. 6.8.5 Beyotime Recent Developments
  49. 6.9 Zymo Research
  50. 6.9.1 Zymo Research Company Information
  51. 6.9.2 Zymo Research Business Overview
  52. 6.9.3 Zymo Research RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Zymo Research RNA Stabilizers Product Portfolio
  54. 6.9.5 Zymo Research Recent Developments
  55. 6.10 Takara Bio
  56. 6.10.1 Takara Bio Company Information
  57. 6.10.2 Takara Bio Business Overview
  58. 6.10.3 Takara Bio RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Takara Bio RNA Stabilizers Product Portfolio
  60. 6.10.5 Takara Bio Recent Developments
  61. 6.11 SRL
  62. 6.11.1 SRL Company Information
  63. 6.11.2 SRL Business Overview
  64. 6.11.3 SRL RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 SRL RNA Stabilizers Product Portfolio
  66. 6.11.5 SRL Recent Developments
  67. 6.12 Omega Bio-Tek
  68. 6.12.1 Omega Bio-Tek Company Information
  69. 6.12.2 Omega Bio-Tek Business Overview
  70. 6.12.3 Omega Bio-Tek RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Omega Bio-Tek RNA Stabilizers Product Portfolio
  72. 6.12.5 Omega Bio-Tek Recent Developments
  73. 6.13 NZYtech
  74. 6.13.1 NZYtech Company Information
  75. 6.13.2 NZYtech Business Overview
  76. 6.13.3 NZYtech RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 NZYtech RNA Stabilizers Product Portfolio
  78. 6.13.5 NZYtech Recent Developments
  79. 6.14 New England Biolabs
  80. 6.14.1 New England Biolabs Company Information
  81. 6.14.2 New England Biolabs Business Overview
  82. 6.14.3 New England Biolabs RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 New England Biolabs RNA Stabilizers Product Portfolio
  84. 6.14.5 New England Biolabs Recent Developments
  85. 6.15 Genetix Biotech Asia
  86. 6.15.1 Genetix Biotech Asia Company Information
  87. 6.15.2 Genetix Biotech Asia Business Overview
  88. 6.15.3 Genetix Biotech Asia RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Genetix Biotech Asia RNA Stabilizers Product Portfolio
  90. 6.15.5 Genetix Biotech Asia Recent Developments
  91. 6.16 G-Biosciences
  92. 6.16.1 G-Biosciences Company Information
  93. 6.16.2 G-Biosciences Business Overview
  94. 6.16.3 G-Biosciences RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 G-Biosciences RNA Stabilizers Product Portfolio
  96. 6.16.5 G-Biosciences Recent Developments
  97. 6.17 Dutscher
  98. 6.17.1 Dutscher Company Information
  99. 6.17.2 Dutscher Business Overview
  100. 6.17.3 Dutscher RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Dutscher RNA Stabilizers Product Portfolio
  102. 6.17.5 Dutscher Recent Developments
  103. 6.18 BioEntist
  104. 6.18.1 BioEntist Company Information
  105. 6.18.2 BioEntist Business Overview
  106. 6.18.3 BioEntist RNA Stabilizers Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 BioEntist RNA Stabilizers Product Portfolio
  108. 6.18.5 BioEntist Recent Developments
7 North America by Country
  1. 7.1 North America RNA Stabilizers Sales by Country
  2. 7.1.1 North America RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America RNA Stabilizers Sales by Country (2021-2026)
  4. 7.1.3 North America RNA Stabilizers Sales Forecast by Country (2027-2032)
  5. 7.2 North America RNA Stabilizers Market Size by Country
  6. 7.2.1 North America RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America RNA Stabilizers Market Size by Country (2021-2026)
  8. 7.2.3 North America RNA Stabilizers Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe RNA Stabilizers Sales by Country
  2. 8.1.1 Europe RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe RNA Stabilizers Sales by Country (2021-2026)
  4. 8.1.3 Europe RNA Stabilizers Sales Forecast by Country (2027-2032)
  5. 8.2 Europe RNA Stabilizers Market Size by Country
  6. 8.2.1 Europe RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe RNA Stabilizers Market Size by Country (2021-2026)
  8. 8.2.3 Europe RNA Stabilizers Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific RNA Stabilizers Sales by Country
  2. 9.1.1 Asia-Pacific RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific RNA Stabilizers Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific RNA Stabilizers Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific RNA Stabilizers Market Size by Country
  6. 9.2.1 Asia-Pacific RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific RNA Stabilizers Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific RNA Stabilizers Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America RNA Stabilizers Sales by Country
  2. 10.1.1 South America RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America RNA Stabilizers Sales by Country (2021-2026)
  4. 10.1.3 South America RNA Stabilizers Sales Forecast by Country (2027-2032)
  5. 10.2 South America RNA Stabilizers Market Size by Country
  6. 10.2.1 South America RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America RNA Stabilizers Market Size by Country (2021-2026)
  8. 10.2.3 South America RNA Stabilizers Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa RNA Stabilizers Sales by Country
  2. 11.1.1 Middle East and Africa RNA Stabilizers Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa RNA Stabilizers Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa RNA Stabilizers Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa RNA Stabilizers Market Size by Country
  6. 11.2.1 Middle East and Africa RNA Stabilizers Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa RNA Stabilizers Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa RNA Stabilizers Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 RNA Stabilizers Value Chain Analysis
  2. 12.1.1 RNA Stabilizers Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 RNA Stabilizers Production Mode & Process
  7. 12.2 RNA Stabilizers Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 RNA Stabilizers Distributors
  10. 12.2.3 RNA Stabilizers Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst